Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 69, Issue 3, 2010, Pages 529-535

  Hanly, J G ^a   Urowitz, M B ^b   Su, L ^c   Bae, S C ^d   Gordon, C ^e   Wallace, D J ^f   Clarke, A ^g   Bernatsky, S ^g   Isenberg, D ^h   Rahman, A ^h   Alarcon G S ⁱ   Gladman, D D ^b   Fortin, P R ^b   Sanchez Guerrero, J ^j   Romero Diaz, J ^j   Merrill, J T ^k   Ginzler, E ^l   Bruce, I N ^m   Steinsson, K ⁿ   Khamashta, M ^o   Petri, M ^p   Manzi, S ^q   Dooley, M A ^r   Ramsey Goldman, R ^s   Van Vollenhoven, R ^t   Nived, O ^u   Sturfelt, G ^u   Aranow, C ^v   Kalunian, K ^w   Ramos Casals, M ^x   Zoma, A ^y   Douglas, J ^a   Thompson, K ^a   Farewell, V ^c   more..

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MRC BIOSTATISTICS UNIT   (United Kingdom)

^d Hanyang University   (South Korea)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MONTREAL GENERAL HOSPITAL   (Canada)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁱ University of Alabama at Birmingham   (United States)

^j INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^k OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^l SUNY Downstate Medical Center   (United States)

^m UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁿ LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^o ST THOMAS HOSPITAL   (United Kingdom)

^p JOHNS HOPKINS UNIVERSITY   (United States)

^q UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF NORTH CAROLINA   (United States)

^s NORTHWESTERN UNIVERSITY   (United States)

^t KAROLINSKA INSTITUTE   (Sweden)

^u LUND UNIVERSITY HOSPITAL   (Sweden)

^v NewYork Presbyterian Hospital   (United States)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x HOSPITAL CLÍNIC   (Spain)

^y HAIRMYRES HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; NEUROPSYCHIATRY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; QUALITY OF LIFE; YOUNG ADULT;

EID: 77949438167     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.106351     Document Type: Article

References (36)

1. Ainiala H, Hietaharju A, Loukkola J, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001;45:419-23.
2. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-20.
3. Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004;31:2156-62.
4. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30:985-92.
5. Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002;29:1536-42.
6. Hanly JG, Urowitz MB, Su L, et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum 2008;59:721-9.
7. Isenberg D, Ramsey-Goldman R; SLICC Group. Systemic Lupus International Collaborating Group - onwards and upwards? Lupus 2006;15:606-7.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
9. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
10. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
11. Thumboo J, Fong KY, Ng TP, et al. Validation of the MOS SF-36 for quality of life assessment of patients with systemic lupus erythematosus in Singapore. J Rheumatol 1999;26:97-102.
12. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
13. Hanly JG, Urowitz MB, Siannis F, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 2008;58:843-53.
14. Karlson EW, Liang MH, Eaton H, et al. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum 2004;50:1832-41.
15. Mok CC, Lau CS, Wong RW. Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study. Am J Med 2003;115:59-62.
16. Barile-Fabris L, Ariza-Andraca R, Olguín-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005;64:620-5.
17. McCune WJ, Golbus J, Zeldes W, et al. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med 1988;318:1423- 31.
18. Tokunaga M, Saito K, Kawabata D, et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis 2007;66:470-5.
19. Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:1311-20.
20. Karassa FB, Ioannidis JP, Boki KA, et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 2000;109:628-34.
21. Jönsen A, Bengtsson AA, Nived O, et al. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford) 2002;41:1308-12.
22. Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum 2003;48:1771-4.
23. Cush JJ. Early rheumatoid arthritis - is there a window of opportunity? J Rheumatol Suppl 2007;80:1-7.
24. Tam LS, Wong A, Mok VC, et al. The relationship between neuropsychiatric, clinical, and laboratory variables and quality of life of Chinese patients with systemic lupus erythematosus. J Rheumatol 2008;35:1038-45.
25. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56:265-73.
26. Hanly JG, Cassell K, Fisk JD. Cognitive function in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 1997;40:1542-3.
27. Hanly JG, Fisk JD, Sherwood G, et al. Clinical course of cognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1994;21:1825-31.
28. Gladman DD, Koh DR, Urowitz MB, et al. Lost-to-follow-up study in systemic lupus erythematosus (SLE). Lupus 2000;9:363-7.
29. Moss KE, Ioannou Y, Sultan SM, et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis 2002;61:409-13.
30. Bertoli AM, Fernández M, Calvo-Alén J, et al. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXXI: factors associated with patients being lost to follow-up. Lupus 2006;15:19-25.
31. Gonzalez-Crespo MR, Blanco FJ, Ramos A, et al. Magnetic resonance imaging of the brain in systemic lupus erythematosus. Br J Rheumatol 1995;34:1055-60.
32. Kozora E, West SG, Kotzin BL, et al. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998;41:41-7.
33. Waterloo K, Omdal R, Husby G, et al. Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Oxford) 2002;41:411-15.
34. Hay EM, Huddy A, Black D, et al. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis 1994;53:298-303.
35. Carlomagno S, Migliaresi S, Ambrosone L, et al. Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 2000;247:273-9.
36. Ginsburg KS, Wright EA, Larson MG, et al. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 1992;35:776-82.